BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 4
• 5
• 8
• 9
• 10
• 11
• 12
• 15
• 16
• 17
• 18
• 19
• 21
• 22
• 23
• 24
• 25
• 26
• 28
• 29
• 30

• Press Releases

  UPDATE -- ADvantage Therapeutics Awarded $2.5 Million NIH SBIR Grant to Advance Alzheimer’s Drug Candidate AD04® Toward the Clinic

  September 29, 2025

   · 

  4 min read
• Press Releases

  New Data Presented on Givinostat for Treatment of Duchenne Muscular Dystrophy at 2025 Neuromuscular Study Group Annual Scientific Meeting

  September 29, 2025

   · 

  8 min read
• Press Releases

  Sanofi expands patient affordability program by offering access to all its insulins for $35 per month in the US

  September 29, 2025

   · 

  5 min read
• Press Releases

  Amneal Announces BLA Submission of Biosimilar Candidate to XOLAIR® (omalizumab)

  September 29, 2025

   · 

  5 min read
• Press Releases

  BioVie to Host Live Investor Webinar and Q&A on Oct. 8

  September 29, 2025

   · 

  3 min read
• Press Releases

  Soligenix Announces Pricing of $7.5 Million Public Offering

  September 29, 2025

   · 

  7 min read
• Press Releases

  Evkeeza® (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol

  September 29, 2025

   · 

  14 min read
• Press Releases

  Fractyl Health Announces Groundbreaking Data from REMAIN-1 Midpoint Cohort Showing Revita® Maintained Weight Loss After GLP-1 Discontinuation

  September 29, 2025

   · 

  9 min read
• Press Releases

  Fractyl Health Announces Pricing of $60 Million Underwritten Offering of Common Stock

  September 29, 2025

   · 

  7 min read
• Press Releases

  Harrow to Acquire Melt Pharmaceuticals

  September 29, 2025

   · 

  8 min read